September 25th-27th, 2017 | Harvard School of Public Health,Boston, MA Dr. Ware will present his annual lecture entitled “New Techniques for Health Outcomes Measurement and Evaluation” at the Measurement, Design, and Analysis Methods for Health Outcomes Research course held from September 25-27 at the Harvard School of Public Health. The lecture will cover the 40-year evolution of survey content and noteworthy milestones in the history of patient-reported outcomes (PROs) as well as some of the most innovative and important recent conceptual and methodological advances.  The latter include new features of items shown to improve their performance over legacy items, standardized underlying metrics for the domains common to most legacy generic PROs, and a new generation of standardized disease-specific PROs that fill the gap between disease-specific symptoms that are not QOL and generic QOL measures that are not disease-specific.  In the afternoon workshop, entitled “The How and Why of Integrating Disease-Specific and Generic Patient-Reported Outcome Measures (PROMS)”, Dr. Ware will discuss the use of QOL impact attributions to specific diseases to improve the validity and responsiveness of disease-specific measures, how improved measures can be integrated and compared in a profile that can be standardized across diseases, and the first norm-based scoring for disease-specific measures for the chronically-ill population.  Case studies from early adoptions of these advances in academic medical center applications and clinical trials will be discussed. 

October 10th, 2013 | Worcester, MA Dr. Ware lectured on "The Impact of Health Care: Quantifying the Voice of the Patient," one of four presentations during the Albert Sherman Center Inaugural Scientific Symposium at the UMass Medical School on October 10th, 2013. Other speakers included Joseph Goldstein and Michael Brown (University of Texas Southwestern Medical Center) who summarized their Nobel Prize winning discoveries in 2-part lectures entitled: "A Century of Cholesterol and Coronaries." Robert Langer (Massachusetts Institute of Technology) lectured on "Controlled Drug Delivery and Tissue Engineering for Angiogenesis Inhibitors." Dr. Ware demonstrated advances in psychometric methods and Internet-based surveys that are fundamental to understanding patient functioning and well-being outcomes in clinical research and practice.

August 17th – 19th, 2015 | Harvard School of Public Health, Boston, MA Dr. Ware presented his annual lecture entitled “New Techniques for Health Outcomes Measurement and Evaluation” at the Measurement, Design, and Analysis Methods for Health Outcomes Research course held from August 17-19 at the Harvard School of Public Health. The lecture covered noteworthy milestones in the history of patient-reported outcomes (PRO) as well as some of the most innovative and important recent conceptual and methodological advances.  The latter included a new generation of standardized (both content and scoring) disease-specific PROs that fill the gap between widely-used disease-specific measures that are not QOL and generic QOL measures that are not disease-specific.  In the afternoon workshop, entitled “Integrating Generic and Disease-Specific Assessments:  What Are the Issues?”  Dr. Ware discussed how both the content and scoring of disease-specific QOL impact measures can be standardized across diseases and how norm-based scoring of disease-specific measures can be accomplished in the chronically-ill population.  The recently-published QOL Disease-Specific Impact Scale (QDIS®) was used to illustrate how the convergent and discriminant validity of disease-specific QOL impact ratings is being tested among adults with multiple comorbid conditions (MCC) in an ongoing NIH/AHRQ-sponsored study.  A second case study from an ongoing national registry will focus on a powerful new adaptive survey logic that automatically adapts to the presence of  MCC while also estimating outcomes equivalent to the metrics underlying widely-used legacy PROs without administering the latter.  Despite the more comprehensive information collected in this small-sample field test,  surveys […]